The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Exelixis
Travel, Accommodations, Expenses - Exelixis; Exelixis (I)
 
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Merck
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Janssen; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck; Roche
Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC).
 
Lorenza Rimassa
Honoraria - Abbvie; AstraZeneca
Consulting or Advisory Role - Amgen; ArQule; Baxter; Bayer; Exelixis; Ipsen; Italfarmaco; Lilly; Sanofi; Sirtex Medical
Travel, Accommodations, Expenses - ArQule; Ipsen
 
Irfan Cicin
No Relationships to Disclose
 
Jean-Frédéric Blanc
Honoraria - Baxalta/Shire; Bayer Schering Pharma; Gilead Sciences
Consulting or Advisory Role - Baxalta/Shire; Bristol-Myers Squibb; Novartis; Onxeo
Travel, Accommodations, Expenses - Bayer Schering Pharma
 
Heinz Josef Klümpen
Consulting or Advisory Role - Ipsen
Travel, Accommodations, Expenses - Ipsen
 
Vittorina Zagonel
No Relationships to Disclose
 
Albert Tran
Honoraria - Abbvie; Gilead Sciences; MSD
Consulting or Advisory Role - Abbvie; Gilead Sciences; MSD
Speakers' Bureau - Abbvie; Gilead Sciences; MSD
Research Funding - Abbvie; Gilead Sciences; MSD
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; MSD
 
Stefano Chong Hun Kim
No Relationships to Disclose
 
Zhong-Zhe Lin
No Relationships to Disclose
 
Vincent C. Tam
Honoraria - Apobiologix; Celgene
Travel, Accommodations, Expenses - Amgen
 
Saswati Hazra
No Relationships to Disclose
 
Milan Mangeshkar
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
Other Relationship - Exelixis
 
Anthony El-Khoueiry
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche
Speakers' Bureau - Merrimack
Research Funding - Astex Pharmaceuticals
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech; GlaxoSmithKline
 
Ann-Lii Cheng
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Merck Serono; Novartis; Ono Pharmaceutical; ONXEO
Speakers' Bureau - Novartis
Research Funding - Sanofi
 
Tim Meyer
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Research Funding - Bayer (Inst); BTG (Inst); Ipsen (Inst)
 
Robin Kate Kelley
Consulting or Advisory Role - Agios (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst)
Research Funding - Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Exelixis (Inst); Lilly (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Target Pharmasolutions (Inst); Tekmira (Inst)
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Agios; Amgen; Antengene; Aptus Clinical; ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb (I); CARsgen Therapeutics; CASI Pharmaceuticals; Celgene; Celgene (I); Celsion; CytomX Therapeutics (I); Daiichi Sankyo; Debiopharm Group; Delcath Systems; Eisai; EMD Serono (I); Exelixis; Gilead Sciences (I); Halozyme; Halozyme (I); Inovio Pharmaceuticals; Ipsen; Medimmune; Merck Serono; Onxeo; PCI Biotech; Roche; Sanofi (I); SERVIER; Silenseed (I); Sillajen; Sirtex Medical; Sirtex Medical; Vicus Therapeutics (I); Yakult Pharmaceutical
Research Funding - Agios (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Exelixis (Inst); Genentech (Inst); Incyte (Inst); Lilly (Inst); MabVax (Inst); MedImmune (Inst); Momenta Pharmaceuticals (Inst); Novartis (Inst); OncoMed (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Polaris